BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36270471)

  • 21. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
    Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
    J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
    Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.
    Chen B; Jiang L; Zhong ML; Li JF; Li BS; Peng LJ; Dai YT; Cui BW; Yan TQ; Zhang WN; Weng XQ; Xie YY; Lu J; Ren RB; Chen SN; Hu JD; Wu DP; Chen Z; Tang JY; Huang JY; Mi JQ; Chen SJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):373-378. PubMed ID: 29279377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods.
    Su D; Zhang D; Chen K; Lu J; Wu J; Cao X; Ying L; Jin Q; Ye Y; Xie Z; Xiong L; Mao W; Li F
    J Exp Clin Cancer Res; 2017 Sep; 36(1):121. PubMed ID: 28882180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.
    Wu D; Sherwood A; Fromm JR; Winter SS; Dunsmore KP; Loh ML; Greisman HA; Sabath DE; Wood BL; Robins H
    Sci Transl Med; 2012 May; 4(134):134ra63. PubMed ID: 22593176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
    Heesch S; Goekbuget N; Stroux A; Tanchez JO; Schlee C; Burmeister T; Schwartz S; Blau O; Keilholz U; Busse A; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Haematologica; 2010 Jun; 95(6):942-9. PubMed ID: 20435628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia].
    Zhao XF; Wang HY; Zhao X; Cheng HC; Li W; Liu SW; Qiu L; Ma J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):947-952. PubMed ID: 30111389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
    Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
    BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
    Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-exome sequencing reveals the subclonal expression of NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.
    Tsurusaki Y; Nagai JI; Fujita S; Sugiyama M; Nakamura W; Hayashi A; Miyagawa N; Keino D; Yokosuka T; Iwasaki F; Hamanoue S; Shiomi M; Goto S; Kurosawa K; Goto H
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28019. PubMed ID: 31556219
    [No Abstract]   [Full Text] [Related]  

  • 35. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk stratification of T-cell Acute Lymphoblastic Leukemia patients based on gene expression, mutations and copy number variation.
    Mirji G; Bhat J; Kode J; Banavali S; Sengar M; Khadke P; Sait O; Chiplunkar S
    Leuk Res; 2016 Jun; 45():33-9. PubMed ID: 27070758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.
    Koschmieder S; Burmeister T; Brüggemann M; Berkemeier A; Volpert S; Wieacker P; Silling G; Gökbuget N; Müller-Tidow C; Berdel WE; Stelljes M
    Leukemia; 2014 Feb; 28(2):419-22. PubMed ID: 24048416
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.
    D'Angiò M; Valsecchi MG; Testi AM; Conter V; Nunes V; Parasole R; Colombini A; Santoro N; Varotto S; Caniglia M; Silvestri D; Consarino C; Levati L; Magrin E; Locatelli F; Basso G; Foà R; Biondi A; Cazzaniga G
    Haematologica; 2015 Jan; 100(1):e10-3. PubMed ID: 25304610
    [No Abstract]   [Full Text] [Related]  

  • 39. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
    La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
    Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric T-cell acute lymphoblastic leukemia.
    Karrman K; Johansson B
    Genes Chromosomes Cancer; 2017 Feb; 56(2):89-116. PubMed ID: 27636224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.